BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Gupta U, Kesharwani P, Ravichandiran V, Kumar P, Naidu VGM, Murty US, Ajazuddin, Alexander A. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J Control Release 2020;327:235-65. [PMID: 32739524 DOI: 10.1016/j.jconrel.2020.07.044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Guan W, Ma Y, Ding S, Liu Y, Song Z, Liu X, Tang L, Wang Y. The technology for improving stability of nanosuspensions in drug delivery. J Nanopart Res 2022;24. [DOI: 10.1007/s11051-022-05403-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tan Y, Liu Y, Liu Y, Ma R, Luo J, Hong H, Chen X, Wang S, Liu C, Zhang Y, Chen T. Rational Design of Thermosensitive Hydrogel to Deliver Nanocrystals with Intranasal Administration for Brain Targeting in Parkinson's Disease. Research (Wash D C) 2021;2021:9812523. [PMID: 34888525 DOI: 10.34133/2021/9812523] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yokel RA. Direct nose to the brain nanomedicine delivery presents a formidable challenge. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1767. [PMID: 34957707 DOI: 10.1002/wnan.1767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Costa CP, Barreiro S, Moreira JN, Silva R, Almeida H, Sousa Lobo JM, Silva AC. In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). Pharmaceuticals (Basel) 2021;14:711. [PMID: 34451808 DOI: 10.3390/ph14080711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hasan N, Imran M, Kesharwani P, Khanna K, Karwasra R, Sharma N, Rawat S, Sharma D, Ahmad FJ, Jain GK, Bhatnagar A, Talegaonkar S. Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose. Int J Pharm 2021;599:120428. [PMID: 33662465 DOI: 10.1016/j.ijpharm.2021.120428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chen Y, Liu Y, Xie J, Zheng Q, Yue P, Chen L, Hu P, Yang M. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine. Int J Nanomedicine 2020;15:10435-51. [PMID: 33380794 DOI: 10.2147/IJN.S265659] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang L, Tang S, Yu Y, Lv Y, Wang A, Yan X, Li N, Sha C, Sun K, Li Y. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Mol Pharm 2021;18:915-27. [PMID: 33417456 DOI: 10.1021/acs.molpharmaceut.0c00911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Poustforoosh A, Nematollahi MH, Hashemipour H, Pardakhty A. Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Noreen S, Murtaza G. Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature. Int J Nanomedicine 2021;16:7517-33. [PMID: 34795481 DOI: 10.2147/IJN.S333657] [Reference Citation Analysis]
10 Patel HP, Chaudhari PS, Gandhi PA, Desai BV, Desai DT, Dedhiya PP, Vyas BA, Maulvi FA. Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. Int J Pharm 2021;600:120474. [PMID: 33737093 DOI: 10.1016/j.ijpharm.2021.120474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 A P, Agrawal M, Dethe MR, Ahmed H, Yadav A, Gupta U, Alexander A. Nose-to-brain drug delivery for the treatment of Alzheimer's Disease: Current advancements and challenges. Expert Opin Drug Deliv 2022. [PMID: 35040728 DOI: 10.1080/17425247.2022.2029845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li Y, Wu H, Jiang X, Dong Y, Zheng J, Gao J. New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.04.001] [Reference Citation Analysis]
13 Ourani-Pourdashti S, Mirzaei E, Heidari R, Ashrafi H, Azadi A. Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery. Int J Biol Macromol 2022;213:1115-26. [PMID: 35691430 DOI: 10.1016/j.ijbiomac.2022.06.031] [Reference Citation Analysis]
14 Gao Y, Liu Y, Qin X, Guo Z, Li D, Li C, Wan H, Zhu F, Li J, Zhang Z, He S. Dual stimuli-responsive fungicide carrier based on hollow mesoporous silica/hydroxypropyl cellulose hybrid nanoparticles. J Hazard Mater 2021;414:125513. [PMID: 34030404 DOI: 10.1016/j.jhazmat.2021.125513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wu J, Shin H, Lee J, Kim S, Lee H. Preparation of External Stimulus-Free Gelatin-Catechol Hydrogels with Injectability and Tunable Temperature Responsiveness. ACS Appl Mater Interfaces 2021. [PMID: 34935360 DOI: 10.1021/acsami.1c19151] [Reference Citation Analysis]
16 Wu D, Fei F, Zhang Q, Wang X, Gong Y, Chen X, Zheng Y, Tan B, Xu C, Xie H, Fang W, Chen Z, Wang Y. Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy. Sci Adv 2022;8:eabm3381. [PMID: 35020438 DOI: 10.1126/sciadv.abm3381] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Phuna ZX, Panda BP, Shivashekaregowda NKH, Madhavan P. Recent development in nanocrystal based drug delivery for neurodegenerative diseases: Scope, challenges, current and future prospects. Journal of Drug Delivery Science and Technology 2022;68:102921. [DOI: 10.1016/j.jddst.2021.102921] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rawal SU, Patel BM, Patel MM. New Drug Delivery Systems Developed for Brain Targeting. Drugs 2022. [PMID: 35596879 DOI: 10.1007/s40265-022-01717-z] [Reference Citation Analysis]
19 Deruyver L, Rigaut C, Lambert P, Haut B, Goole J. The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Adv Drug Deliv Rev 2021;175:113826. [PMID: 34119575 DOI: 10.1016/j.addr.2021.113826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Wu H, Zhou Y, Wang Y, Tong L, Wang F, Song S, Xu L, Liu B, Yan H, Sun Z. Current State and Future Directions of Intranasal Delivery Route for Central Nervous System Disorders: A Scientometric and Visualization Analysis. Front Pharmacol 2021;12:717192. [PMID: 34322030 DOI: 10.3389/fphar.2021.717192] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Dubey SK, Parab S, Dabholkar N, Agrawal M, Singhvi G, Alexander A, Bapat RA, Kesharwani P. Oral peptide delivery: challenges and the way ahead. Drug Discov Today 2021;26:931-50. [PMID: 33444788 DOI: 10.1016/j.drudis.2021.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Annu, Sartaj A, Qamar Z, Md S, Alhakamy NA, Baboota S, Ali J. An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor. Front Bioeng Biotechnol 2022;10:788128. [DOI: 10.3389/fbioe.2022.788128] [Reference Citation Analysis]
23 Thapa R, Gurung S, Parat M, Parekh HS, Pandey P. Application of Sol–Gels for Treatment of Gynaecological Conditions—Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery. Gels 2022;8:99. [DOI: 10.3390/gels8020099] [Reference Citation Analysis]
24 Agrawal M, Prathyusha E, Ahmed H, Dubey SK, Kesharwani P, Singhvi G, Naidu VGM, Alexander A. Biomaterials in treatment of Alzheimer's disease. Neurochem Int 2021;145:105008. [PMID: 33684545 DOI: 10.1016/j.neuint.2021.105008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bekhet MA, Ali AA, Kharshoum RM, El-ela FIA, Salem HF. Intranasal Niosomal in situ Gel as a Novel Strategy for Improving Citicoline Efficacy and Brain Delivery in Treatment of Epilepsy: In vitro and ex vivo characterization and in vivo pharmacodynamics investigation. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.02.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Nie T, Wang W, Liu X, Wang Y, Li K, Song X, Zhang J, Yu L, He Z. Sustained Release Systems for Delivery of Therapeutic Peptide/Protein. Biomacromolecules 2021;22:2299-324. [PMID: 33957752 DOI: 10.1021/acs.biomac.1c00160] [Reference Citation Analysis]
27 Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G, Ajazuddin, Alexander A. Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design. Biomed Pharmacother 2021;141:111919. [PMID: 34328108 DOI: 10.1016/j.biopha.2021.111919] [Reference Citation Analysis]
28 Lacroce E, Rossi F. Polymer-based thermoresponsive hydrogels for controlled drug delivery. Expert Opin Drug Deliv 2022. [PMID: 35575265 DOI: 10.1080/17425247.2022.2078806] [Reference Citation Analysis]
29 Agrawal M, Pradhan M, Singhvi G, Patel R, Ajazuddin, Alexander A. Thermoresponsive in situ gel of curcumin loaded solid lipid nanoparticle: Design, optimization and in vitro characterization. Journal of Drug Delivery Science and Technology 2022;71:103376. [DOI: 10.1016/j.jddst.2022.103376] [Reference Citation Analysis]
30 Zhou Z, Sun T, Jiang C. Recent advances on drug delivery nanocarriers for cerebral disorders. Biomed Mater 2021;16:024104. [PMID: 33455956 DOI: 10.1088/1748-605X/abdc97] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease. J Control Release 2022:S0168-3659(22)00058-X. [PMID: 35114208 DOI: 10.1016/j.jconrel.2022.01.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Gutierrez AM, Frazar EM, X Klaus MV, Paul P, Hilt JZ. Hydrogels and Hydrogel Nanocomposites: Enhancing Healthcare through Human and Environmental Treatment. Adv Healthc Mater 2022;11:e2101820. [PMID: 34811960 DOI: 10.1002/adhm.202101820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Antimisiaris SG, Marazioti A, Kannavou M, Natsaridis E, Gkartziou F, Kogkos G, Mourtas S. Overcoming barriers by local drug delivery with liposomes. Adv Drug Deliv Rev 2021;174:53-86. [PMID: 33539852 DOI: 10.1016/j.addr.2021.01.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 50.0] [Reference Citation Analysis]
34 Cassano R, Servidio C, Trombino S. Biomaterials for Drugs Nose-Brain Transport: A New Therapeutic Approach for Neurological Diseases. Materials (Basel) 2021;14:1802. [PMID: 33917404 DOI: 10.3390/ma14071802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ma J, Wang C, Sun Y, Pang L, Zhu S, Liu Y, Zhu L, Zhang S, Wang L, Du L. Comparative study of oral and intranasal puerarin for prevention of brain injury induced by acute high-altitude hypoxia. Int J Pharm 2020;591:120002. [PMID: 33141084 DOI: 10.1016/j.ijpharm.2020.120002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Vora D, Kincaid AE, Tolman J, Chauhan H. Characterization and Systemic Delivery of Dibenzoylmethane via the Intranasal Route. AAPS PharmSciTech 2021;22:30. [PMID: 33404926 DOI: 10.1208/s12249-020-01904-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Magdy M, Elmowafy E, Elassal M, Ishak RA. Localized drug delivery to the middle ear: Recent advances and perspectives for the treatment of middle and inner ear diseases. Journal of Drug Delivery Science and Technology 2022;69:103149. [DOI: 10.1016/j.jddst.2022.103149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Schilling AL, Cannon E, Lee SE, Wang EW, Little SR. Advances in controlled drug delivery to the sinonasal mucosa. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121430] [Reference Citation Analysis]
39 Goel H, Kalra V, Verma SK, Dubey SK, Tiwary AK. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. J Control Release 2021;341:782-811. [PMID: 34906605 DOI: 10.1016/j.jconrel.2021.12.009] [Reference Citation Analysis]
40 Wang JT, Rodrigo AC, Patterson AK, Hawkins K, Aly MMS, Sun J, Al Jamal KT, Smith DK. Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self-Healing Supramolecular Gel. Adv Sci (Weinh) 2021;8:e2101058. [PMID: 34029010 DOI: 10.1002/advs.202101058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
41 Dubey SK, Bhatt T, Agrawal M, Saha RN, Saraf S, Saraf S, Alexander A. Application of chitosan modified nanocarriers in breast cancer. Int J Biol Macromol 2022;194:521-38. [PMID: 34822820 DOI: 10.1016/j.ijbiomac.2021.11.095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
42 Zingale E, Bonaccorso A, Carbone C, Musumeci T, Pignatello R. Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications. Pharmaceutics 2022;14:691. [PMID: 35456525 DOI: 10.3390/pharmaceutics14040691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Gyanewali S, Kesharwani P, Sheikh A, Ahmad FJ, Trivedi R, Talegaonkar S. Formulation development and in vitro-in vivo assessment of protransfersomal gel of anti-resorptive drug in osteoporosis treatment. Int J Pharm 2021;608:121060. [PMID: 34500057 DOI: 10.1016/j.ijpharm.2021.121060] [Reference Citation Analysis]
44 Kaur H, Kesharwani P. Advanced nanomedicine approaches applied for treatment of skin carcinoma. J Control Release 2021;337:589-611. [PMID: 34364919 DOI: 10.1016/j.jconrel.2021.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zha S, Wong KL, All AH. Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain. Adv Healthc Mater 2022;11:e2102610. [PMID: 35166052 DOI: 10.1002/adhm.202102610] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]